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industrial interest and the pacemaker industry
wasborn. Jeffrey's study illustrates very wellthe
process by which scientific, clinical, and
technical discussion regarding the relative
merits of one or other design is gradually
transformed into competition between
commercial products vying for shares of the
world market. When the Medicare programme
came into operation, in 1966, the overall size of
the pacemaker market grew rapidly, for most
of it was in the USA. Manufacturers prospered.
Further innovation, including the search for
new applications of the device, was then
shaped by the exigencies of the market. A
reputation for technological sophistication was
one competitive strategy, preferred by some
commercial competitors. Others placed more
weight on a reputation for reliability and the
customer-support they provided. These are the
central elements in the history of almost any
modem medical technology. A strength of
Jeffrey's book lies in its comparison of the
pacemakerwiththeimplantabledefibrillatorthat
came later. There were some similarities: the
initial response ofthe clinical community was
once more one of scepticism. What this second
storyillustratesistheeffectofthenewregulatory
climate, and the concern with cost containment,
that emerged in the 1970s, with "technology"
identified as a major culprit. By 1980,
demonstrating clinical safety and efficacy was
no longer enough. Economists had arrived
on the scene.
Machines in our hearts is more a study in the
history of technology than in the history of
medicine. Itwouldbeapityifmedicalhistorians,
or health policy analysts, were put offby the
technicalities. It is precisely thebook's attention
to the motive forces ofreputation-making and
(still more) commercial competition in shaping
these technologies, their uses and their growth,
that helps us understand something of the
fundamental quality of late-twentieth-century
American medicine. Thelastchapter, 'The 1990s
and beyond', looks to the future. Jeffrey
anticipatesthe emergenceofacardiac implant to
treat congestive heart failure (CHF): "the single
mostfrequentcauseofhospitalization inpatients
over age 65". Ifand when it comes, this will be
"an important source of future revenue growth
forthe manufacturers": probably not a matterof
major interest for historians of medicine. But
what of the demarcation of the role of the
cardiologist, for this too may change? Getting
to grips with where innovative health care
technologies come from, how they are affected
by (and affect) our expectations of medicine,
and its organization, surely obliges us to look
across the boundaries of our own scholarly
disciplines too.
Stuart Blume,
University of Amsterdam
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Medical pluralism is a term that social
historians ofmedicine have long associated
with the eighteenth century, but only very
rarely with the early twentieth. The dominating
theme here has not been continuing pluralism
but rather the rise of medical science and the
tendency of modern states and their medical
professions to establish medical monopolies.
Barbara Clow uses the example of cancer
care to analyse the construction ofmedical
authority in Canada, and she suggests that
medical culture in early-twentieth-century
North America was far more pluralistic than
often assumed.
The book centres around the careers of three
popular providers of more or less heterodox
cancercuresintheCanadianprovinceofOntario,
whose influence extended far beyond the
provincial borders. Hendry Connell was a
physicianwhodeveloped anenzymeextractthat,
he believed, dissolved cancer cells by
proteolysis. John Hett, also a doctor,
experimented with a combination ofsera that he
assumed would restore the endocrine balance of
patients and trigger an immune response to the
roguecells. Finally, ReneCaisse, atrainednurse,
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treated cancer sufferers with herbal infusions,
derived, according to her own account, from a
native American recipe.
Clow dedicates the second halfofher book to
explaining why, "while Connell was described
as an experimenter and Hett was depicted as a
maverick, Caisse was considered a quack"
(p. 85). But before she turns to her three
protagonists, she sets the stage with chapters on
the experiences of cancer sufferers in the early
twentieth century and on mainstream medical
practices and concepts dealing with the dread
disease. She presents us with some interesting
illness narratives that show how patients moved
quite freely from orthodox to heterodox
practioners and sometimes theotherway-Clow
describes this as a "continuum ofcare" (p. 116).
Orthodox treatments, mostly surgical, were
drastic and not necessarily more efficient than
what fringe practitioners had to offer.
Furthermore, the immunological, biochemical
and endocrinological models employed by
Connell and Hett seemed well in line with
contemporary medical thought, and all three
set up laboratories where they tested their
formulas on animals.
Inthe 1930s, thenegotiations overwhatwasto
count as legitimate medicine between cancer
sufferers and their relatives, the medical
profession and the state, intensified. Connell,
Hett and Caisse expected the state to embrace
their inventions and were supported in this by
patients and their relatives. The government
appointed a commission to evaluate non-
conventional cancertherapies andatfirstseemed
to follow the demands ofthe organized medical
profession but made considerable concessions
when faced with public protests. In the 1930s,
more than 55,000 people signed petitions on
behalf of Caisse. Connell had long collaborated
with other doctors, and he received government
help for his research. Hett alienated both the
profession and the government by refusing to
revealthe secretofhisrecipe andhadhismedical
licence withdrawn. Caisse also kept her formula
secret. As a nurse, she was never taken seriously
by the medical profession but had the largest
number of followers, and her anti-cancer tea
enjoyed a comeback in the 1970s.
Barbara Clow's interesting and well-
structured book is a valuable contribution to the
growing number of studies in recent years that
suggest that early-twentieth-century medicine
was far less monolithic than often assumed, and
that the confidence in medical science and
mainstream medicine that came to dominate
medical culture in the 1950s and 1960s may
have been an exception rather than the rule.
The book also contributes some important
insightsontheframing ofcancerin thetwentieth
century. The history of the disease has too
oftenbeenwrittenaboutasifitweresynonymous
with the history of cancer research.
Carsten Timmermann,
University of Manchester
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Most studies of the history of asbestos,
health and disease have focused either on
Britain orthe USA. Examinationofthesethemes
in the South African context is therefore
welcome, notleastbecauseofthekeyroleplayed
by South African researchers in the discovery of
the asbestos-related disease, mesothelioma.
Since miners and others alleging ill health as a
resultofexposuretodustintheasbestos fieldsof
southern Africa are currently bringing legal
actions in the British and American courts, it
is also topical.
Although a good deal ofAsbestos blues deals
with living conditions and mining techniques,
medical history is at the heart of the book.
McCullochvilifiesindustry, scientists (evensuch
"heroes" as J C Wagner), state authorities and
defencelawyersforfurtheringtheirowninterests
while playing fast and loose with the lives of
countless South Africans. Above all, the
apartheid system stands accused of generating
large profits for the few while bequeathing
a legacy of environmental degradation, misery
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